New CADTH process for cell and gene therapies

9 January 2020 - CADTH has undertaken an internal review of our processes for drugs and devices, and established a revised ...

Read more →

Revised process for cell and gene therapies

21 November 2019 - CADTH has undertaken an internal review and established a novel process for the review of cell and ...

Read more →

CADTH to review CAR T-cell therapies

17 April 2018 - Since the FDA approved the first gene therapy in 2017, Canadian patients, health care providers, and decision-makers ...

Read more →